Company Search:
Advanced Search
Sponsored Links
Catalis SE Company Snapshot
Catalis SE operates in the Testing laboratories sector. In addition to historical fundamental analyses, the complete report available to purchase compares Catalis SE with three other miscellaneous service companies in Europe: Molecular Partners AG of Switzerland (2016 sales of 23.04 million Swiss Francs [US$24.41 million] of which 100% was Biopharmaceuticals), Molmed S.P.A. of Italy (19.48 million Euro [US$24.14 million] ), and Formycon AG which is based in Germany (19.66 million Euro [US$24.37 million] ).

Sales Analysis. Catalis SE reported sales of 19.37 million Euro (US$24.00 million) for the year ending December of 2016. This represents a decrease of 1.8% versus 2015, when the company's sales were 19.72 million Euro.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Catalis SE
  Stock Performance Chart for Catalis SE
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 24.00
(Figures in Euro)
1 Week 2.6%   13 Weeks -2.4%  
4 Weeks 55.6%   52 Weeks 43.7%  
Catalis SE Key Data:
  Ticker: XAE2 Country: Netherlands
  Exchanges: AMS DUS FRA OTH Major Industry: Commercial Services & Supplies
    Sub Industry: Testing Laboratories
  2016 Sales 19,369,000
(Year Ending Jan 2017).
Employees: 320
  Currency: Euro Market Cap: 16,800,000
  Fiscal Yr Ends: December Shares Outstanding: 700,000
  Share Type: Aandeel Closely Held Shares:
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.